J&J acquired rights to TAR-200 when it bought privately-owned biotech Taris for an undisclosed sum in 2019, and has big sales ...
The New Drug Application for TAR-200 is supported by results from the Phase IIb SunRISe-1 study, which demonstrated an 83.5% ...
Raritan: Johnson & Johnson has announced it has initiated the submission of an original New Drug Application with the U.S.
Three days after landing an offer from first-year UNC football head coach Bill Belichick and his staff while on a visit in ...
Zacks.com on MSN6d
J&J Seeks FDA Nod for Non-Muscle Invasive Bladder Cancer DrugJNJ's regulatory filing seeks the FDA's approval for TAR-200, a drug-device combination for treating certain bladder cancer ...
UNC gave away its second straight game and is now in danger of missing the NCAA Tournament for the second time in three years ...
Johnson & Johnson JNJ has initiated a rolling submission with the FDA seeking approval for TAR-200, its investigational drug-device combination to treat certain patients with non-muscle invasive ...
Newkirk, a 6-foot-3, 200-pound senior regarded by most services as a three-star recruit, recently led Maury to an unbeaten ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback